| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 02/13/2003 | WO2001087286A3 Antisense enzyme inhibitors for improving pharmacokinetics of a drug |
| 02/13/2003 | WO2001060398A8 Drugs for ameliorating impaired glucose tolerance |
| 02/13/2003 | US20030032995 Thermotherapy via targeted delivery of nanoscale magnetic particles |
| 02/13/2003 | US20030032834 Aminoalcohol derivatives |
| 02/13/2003 | US20030032791 Nucleotide sequences coding polypeptide for use in the treatment of metabolic, reproductive and eating disorders |
| 02/13/2003 | US20030032666 Crystalline forms |
| 02/13/2003 | US20030032663 Inhibition of the interaction of RAGE with its ligands; treatment acute and chronic inflammation, the development of diabetic late complications, Alzheimer's disease, erectile dysfunction, and tumor invasion and metastasis. |
| 02/13/2003 | US20030032656 2-Amino-nicotinamide derivatives and their use as vegf-receptor tyrosine kinase inhibitors |
| 02/13/2003 | US20030032636 For the treatment of depression and other affective disorders. |
| 02/13/2003 | US20030032634 Oxidant scavengers for treatment of diabetes or use in transplantation or induction of immune tolerance |
| 02/13/2003 | US20030032633 Use of the active fraction (-)- Olivil as an antioxidant or free radical scavenger. |
| 02/13/2003 | US20030032626 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1) |
| 02/13/2003 | US20030032588 Glucagon antagonists |
| 02/13/2003 | US20030032581 Pharmaceuticals for treating obesity |
| 02/13/2003 | US20030032183 Induction of preferential stem cell differentiation; obtain nutrient broths, inoculate with cells, mix with modulator, propagate and recover cells |
| 02/13/2003 | US20030032179 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 02/13/2003 | US20030032144 Nucleic acid constructs useful for glucose regulated production of human insulin in somatic cell lines |
| 02/13/2003 | US20030032097 DNA encoding human vanilloid receptor VR3 |
| 02/13/2003 | US20030031772 Mixtures of fructose and lactose as a low-calorie bulk sweetener with reduced glyemic index |
| 02/13/2003 | US20030031657 Stem cells and their use in transplantation |
| 02/13/2003 | CA2753329A1 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 02/13/2003 | CA2457100A1 Taste masking composition |
| 02/13/2003 | CA2456192A1 Pyrazole-derived kinase inhibitors and uses thereof |
| 02/13/2003 | CA2456187A1 Pyrazole-derived kinase inhibitors and uses thereof |
| 02/13/2003 | CA2455963A1 Glp-1 exendin-4 peptide analogs and uses thereof |
| 02/13/2003 | CA2455833A1 1,3,5-triazine-2,4,6-triones, preparation and use as gonadotropin-releasing hormone receptor antagonists |
| 02/13/2003 | CA2455753A1 Novel 2,4-diaminothiazole derivatives |
| 02/13/2003 | CA2455749A1 Butyric acid derivatives |
| 02/13/2003 | CA2455398A1 Use of peptide fragments of the calcium channel .alpha.-1 subunit, optionally comprising mutations, for screening molecules of therapeutic interest |
| 02/13/2003 | CA2455228A1 Antisense modulation of apolipoprotein b expression |
| 02/13/2003 | CA2455194A1 Vascular endothelial growth factor isoform having anti-angiogenic activity |
| 02/13/2003 | CA2455179A1 Androgen receptor modulators and methods of use thereof |
| 02/13/2003 | CA2454937A1 Modulators of notch signalling for use in immunotherapy |
| 02/13/2003 | CA2454414A1 Use of 2-alkoxyphenyl-substituted imidazotriazinones |
| 02/13/2003 | CA2454159A1 Methods for assessing the risk of obesity based on allelic variations in the 5'-flanking region of the insulin gene |
| 02/13/2003 | CA2453661A1 (-)-olivil as antioxidant |
| 02/13/2003 | CA2453372A1 Methylation resistant vectors |
| 02/13/2003 | CA2453274A1 Thienopyrimidinediones and their use in the modulation of autoimmune disease |
| 02/13/2003 | CA2452743A1 5-arylsulfonyl indoles having 5-ht6 receptor affinity |
| 02/13/2003 | CA2452665A1 Novel vinyl carboxylic acid derivatives and their use as antidiabetics etc. |
| 02/13/2003 | CA2451942A1 Crystallized structure of type iv collagen nc1 domain hexamer |
| 02/13/2003 | CA2451868A1 Pharmaceutical composition comprising lipids comprising a polar and a nonpolar moiety |
| 02/13/2003 | CA2451855A1 Oral pharmaceutical composition comprising an active principle capable of being subjected to high effect during its first passage through the intestine |
| 02/12/2003 | EP1283260A1 Novel insulin/igf/relaxin family polypeptides and dnas thereof |
| 02/12/2003 | EP1283058A1 Agents for preventing or ameliorating insulin resistance and/or obesity |
| 02/12/2003 | EP1283054A1 Drugs for complications of diabetes and neuropathy and utilization thereof |
| 02/12/2003 | EP1283051A1 Stable insulin formulations |
| 02/12/2003 | EP1283046A1 Preventives and/or remedies for hyperphosphatemia |
| 02/12/2003 | EP1282816A2 Improved assay techniques using nematode worms |
| 02/12/2003 | EP1282687A1 Microorganisms for treatment or prevention of obesity and diabetes mellitus, and pharmaceutical composition containing the same |
| 02/12/2003 | EP1282624A1 Crf receptor antagonists and methods relating thereto |
| 02/12/2003 | EP1282622A1 Crf receptor antagonists and methods relating thereto |
| 02/12/2003 | EP1282619A1 Processes for the preparation of thiazolidinedione derivatives and intermediates |
| 02/12/2003 | EP1282612A2 Alkynyl phenyl heteroaromatic glucokinase activators |
| 02/12/2003 | EP1282611A1 Substituted phenylacetamides and their use as glucokinase activators |
| 02/12/2003 | EP1282610A1 Benzoxazine and benzothiazine derivatives and the use thereof in medicaments |
| 02/12/2003 | EP1282602A1 Propanoic acid derivatives as integrin receptor antagonists |
| 02/12/2003 | EP1282600A1 Inhibitors of dipeptidyl peptidase iv |
| 02/12/2003 | EP1282599A1 Disulfide derivatives useful for treating allergic diseases |
| 02/12/2003 | EP1282432A1 Method of use of peptide antagonists of zonulin to prevent or delay the onset of diabetes |
| 02/12/2003 | EP1282426A1 Nutritional preparation comprising ribose and folic acid and medical use thereof |
| 02/12/2003 | EP1282416A2 Dehydroascorbic acid formulations and uses thereof |
| 02/12/2003 | EP1282414A2 Felbamate derived compounds |
| 02/12/2003 | EP1282410A2 Novel medical use of aldosterone synthase inhibitors alone or in combination with at1-receptor antagonists |
| 02/12/2003 | EP1226239A4 Methods of producing differentiated progenitor cells and lineage-defective embryonic stem cells |
| 02/12/2003 | EP1064262B1 Substituted isoindolones and their use as cyclic gmp modulators in medicaments |
| 02/12/2003 | EP1023314B1 Bile acid salts of metals with physiological action and the use thereof in therapy |
| 02/12/2003 | EP0728147B1 Receptor specific atrial natriuretic peptides |
| 02/12/2003 | CN1396930A Devivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effect |
| 02/12/2003 | CN1396926A Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1, 1-bisphosphonic acid sodium 2.5 hydrate or monohydrate |
| 02/12/2003 | CN1396922A Method for producing 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizine-5-yl acetic acid |
| 02/12/2003 | CN1396920A 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists |
| 02/12/2003 | CN1396915A Heterocylic derivative, its preparation method and medicine composition containing them |
| 02/12/2003 | CN1396912A 2-amino-nicotinamide derivative sand their use as VEGF-receptor tyrosine kinase inhibitors |
| 02/12/2003 | CN1396910A Use of vitamin D-derivatives in treatment of osteoporosis and related bone disorders, as well as novel vitamin D3-derivatives |
| 02/12/2003 | CN1396908A Palatable arginine compounds and uses thereof for cardiovascular health |
| 02/12/2003 | CN1396906A Calcilytic compounds |
| 02/12/2003 | CN1396904A Novel compound, their preparation and use |
| 02/12/2003 | CN1396903A Novel compound, their preparation and use |
| 02/12/2003 | CN1396831A Pharmaceutical preparation and method for treatment of diabetes |
| 02/12/2003 | CN1396830A Pharmaceutical parenteral composition containing biphosphonate |
| 02/12/2003 | CN1396829A New drug combinations |
| 02/12/2003 | CN1396825A Composition, kit for benefitting cardiovasaclaire and method |
| 02/12/2003 | CN1396823A Electrospun pharmaceutical compositions |
| 02/12/2003 | CN1396155A Garlicin extracted reversely by supercritical CO2 and process for preparing its injection |
| 02/12/2003 | CN1395951A Medicine for treating diabetes and its preparing process |
| 02/12/2003 | CN1395928A Slow-releasing acipimox tablet |
| 02/12/2003 | CN1395927A Slow-releasing acipimox capsule |
| 02/12/2003 | CN1395870A Hypoglycemic health-care polypeptide food |
| 02/12/2003 | CN1101223C Production process for whole glossy ganoderma |
| 02/12/2003 | CN1101213C Diabetes treating medicine |
| 02/12/2003 | CN1101199C Chinese-medicinal caspule for treating hyperlipomia |
| 02/12/2003 | CN1101194C Method for preparing salmon spawn oleofinous capsule with high-nutrient and blood-lipid depression |
| 02/12/2003 | CN1101133C Formulation and production process for Baile Biscuit with dietary fiber having hypoglycemic function |
| 02/11/2003 | US6518458 (Aminoiminomethyl) amino) alkane-carboxamides and their applications in therapy |
| 02/11/2003 | US6518435 Production method, a method of producing a compound represented by the formula (III) production method of oxyimino- alkanoic acid derivatives having an anti-diabetic activity. |
| 02/11/2003 | US6518412 Gene therapy approaches to supply apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
| 02/11/2003 | US6518403 Antibodies that bind an adipocyte-specific protein homolog |
| 02/11/2003 | US6518316 Cytokine production and tyrosine kinase inhibitors |
| 02/11/2003 | US6518302 Remedies |